We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Avacta Group Plc | LSE:AVCT | London | Ordinary Share | GB00BYYW9G87 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.30 | -0.66% | 45.00 | 44.50 | 45.50 | 45.25 | 44.25 | 45.25 | 2,905,504 | 16:28:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 10.06M | -39.19M | -0.1382 | -3.26 | 127.63M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/12/2018 08:06 | Thought about buying back in but decided the mark up priced me out risk wise. | dave4545 | |
10/12/2018 08:00 | wow what a deal | dave4545 | |
10/12/2018 07:56 | "AVCT has a market capitalisation of just £26.2m which is way below the investment needed to get the company where it is today. Moreover, in the context of this deal, the current value represents an enormous opportunity that the market is totally overlooking. This deal looks set to be a wake-up call for the market." | 1i1i1i | |
10/12/2018 07:55 | Good luck to all holders (not me).....this might be the beginning providing Alistair doesn't use it as a step for another fundraising. | spekky | |
10/12/2018 07:55 | 30/32 pre market! | nobbygnome | |
10/12/2018 07:46 | greater than six times the market cap from one deal gives people something to chew on and try to calculate fair value. Possible cheeky bidder(s) might throw out an opportunistic offer | the drewster | |
10/12/2018 07:44 | And out of the blue.... | nobbygnome | |
10/12/2018 07:44 | Hardman update out already (I haven't read it yet): | timbo003 | |
10/12/2018 07:43 | Surely this announcement is company changing because of the potential cash and validation of the approach. Difficult to know what the valuation should be....but certainly above this level! | nobbygnome | |
10/12/2018 07:36 | wan ... even though just "potential" I'd be amazed if this doesn't re-rate on this news | the drewster | |
10/12/2018 07:27 | No cash upfront though.....but 'potential' for upfront payments. So no WOW in my book, but it is a good validation. | wan | |
10/12/2018 07:21 | Market cap was £27m as of Friday. 2019 turnover forecast was £3m. Suspect it will take some time for the market to work out the new fair price. | 18bt | |
10/12/2018 07:13 | $180m + $130m = $310m = potential worth. Stonking deal | gersemi | |
10/12/2018 07:10 | Wow indeed😊 | 18bt | |
07/12/2018 18:53 | A few numpties posting today, always a good sign that good times are around the corner. | 1i1i1i | |
07/12/2018 16:06 | hxxps://simplywall.s Under valued at 73p this will fly on good news. Really hope for a string of news soon. | danatkins | |
06/12/2018 12:22 | Yes,I see Dr Smith is making more Jam Tomorrow statements. Seems that any pending deals have now drifted out to 2019? Let's face it Avacta simply can't get serious interest form the sector. Let alone get any meaningful up front payments. I am also very curious as to why we never get any feed back on the reaction to all of these major presentations Avacta are doing. They always seem keen to announce these presentations....but then silence. Worrying! | lantanatony | |
01/12/2018 08:27 | High risk, potentially very high reward... Alistair really needs to gain some commercial traction and get recognition for all of the scientific validations. It would only take one affimer based therapeutic and sentiment would shift massively. | the drewster | |
30/11/2018 21:52 | Patience, all the ducks are being lined up. | 1i1i1i | |
30/11/2018 21:29 | Still no deals eh? But meanwhile, the Management still remain in place along with their questionable Advisors No wonder some people think Yorkshire is God's country! At least it's affordable! | lantanatony | |
26/11/2018 12:23 | Where are the deals? | lantanatony | |
08/11/2018 07:31 | Unlikely ... this does look cautiously promising. | the drewster |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions